ET NEWS

Kolkata: Chinese smartphone maker Vivo Mobile India has said in a regulatory filing with the Registrar of Companies (RoC) that it expects to continue as a "going concern" and manage capital to be financially solvent. The development comes at a time when the company's auditors have flagged concerns in RoC filings over Vivo's ability to be a going concern due to multiple regulatory actions against the company.Vivo, which was the country's largest smartphone maker in the April-June quarter as per researcher IDC India's latest data, said it will maintain "optimal capital structure to reduce cost of capital"."The group manages its capital so as to safeguard its ability to continue as a going concern and to optimise returns to shareholders. The capital structure of the group is based on management's judgement of its strategic and day-to-day needs with a focus on total equity so as to maintain investor, customer, creditors and market confidence," Vivo Mobile India said in the RoC filing.The company's auditor said in its report posted in filing made with the RoC in August that owing to ongoing investigations, tax issues and legal proceedings involving significant amounts under litigation, a "material uncertainty exists that may cast significant doubt on the ability of the company to continue as a going concern".

Food and beverages major PepsiCo on Thursday said international sales of its convenient foods business (snacks) has delivered a 2.5 per cent organic revenue growth in the third quarter of 2025, helped by markets including India. However, its International Beverages Franchise (IBF) segment, which focuses on bottling and distribution of PepsiCo's beverage brands outside of North America, had a decline of one per cent in the September quarter. IBF includes PepsiCo's international franchise beverage businesses as well as its SodaStream business. About its snack business, PepsiCo said: "Our international convenient foods business delivered organic revenue growth of 2.5 per cent in the third quarter and 3 per cent year to date." In the third quarter, organic revenue growth was driven by markets including Mexico, Argentina, Colombia, India, Egypt, Germany, Turkiye, Australia, Pakistan and Vietnam. "Year-to-date (nine months), we held or gained savory snack share in Brazil, Colombia, Guatemala, Puerto Rico, Poland, France, India, Australia and Thailand," said Pepsico in its earnings statement. PepsiCo's net revenue in the third quarter was up 2.65 per cent to USD 23.93 billion. Its operating profit was down 7.8 per cent to USD 3.57 billion for the quarter which ended on September 6, 2025. About the 2025 outlook, PepsiCo Chairman and CEO Ramon Laguarta said: "We continue to expect to deliver low-single-digit organic revenue growth with core constant currency EPS to be approximately even with the prior year. Our full year core USD EPS outlook has improved due to a more favourable outlook on foreign exchange translation rates for the balance of this year." PTI KRH HVA

The Kerala health department on Thursday issued new technical guidelines for treating cough in children and using medicines with special precautions for dispensing them to young patients.The move follows reports of child deaths outside Kerala after consuming cough syrups.A three-member expert panel studied the issue, and the state-specific guidelines were prepared based on its recommendations.The guidelines outline the clinical approach and management of cough, types of cough and related symptoms, persistent and continuous cough, clinical examination of children with cough, investigations, cough control, dosage and safety considerations, non-pharmacological measures, and directions from the Kerala Drugs Controller's circular dated October 4, 2025.Pharmacists must strictly follow the Drugs Controller's directions, an official release said.Special care is required when dispensing medicines for children. Healthcare providers must ensure that medicines are not expired and are procured only from manufacturers with valid quality assurance certificates.The guidelines also contain instructions for the public.Cough is not a disease but a symptom, and self-medication should be avoided, the Health Department advised."Do not demand cough syrups or formulations; use them only on the advice of a paediatric specialist. Do not use leftover medicines or expired prescriptions. A medicine prescribed for one child should not be given to another without consulting a paediatrician," the statement said."In children with cough, if there is chest pain, difficulty breathing, blood in sputum, excessive fatigue, seizures, cyanosis, or altered consciousness, contact a paediatrician immediately. Medicines prescribed by a doctor should be used only in the specified dose and for the prescribed duration," it added.The guidelines caution that cough syrups should not be given to children under two years of age. For those aged two to five, their use should generally be avoided unless specifically prescribed and closely monitored by a doctor.For children above five, medicines should be administered only after careful evaluation in small doses, and for short durations.The health department emphasised that all cough syrups distributed at healthcare centres must comply with manufacturing standards and be free from harmful contaminants such as Diethylene Glycol (DEG) and Ethylene Glycol (EG).Health Minister Veena George said the comprehensive guidelines are meant for doctors, healthcare workers, pharmacists, and the public, and stressed that everyone must strictly adhere to them.